A large real-world cohort study of examined lymph node standards for adequate nodal staging in early non-small cell lung cancer

Authors:
  • ZZZhihua Zhu
    Zhihua Zhu
  • ZSZhengbo Song
    Zhengbo Song
  • WJWenjie Jiao
    Wenjie Jiao
  • WMWeijian Mei
    Weijian Mei
  • CXChunwei Xu
    Chunwei Xu
  • QHQinghua Huang
    Qinghua Huang
  • CAChaolun An
    Chaolun An
  • JSJianguang Shi
    Jianguang Shi
  • WWWenxian Wang
    Wenxian Wang
  • GYGuiping Yu
    Guiping Yu
  • PSPingli Sun
    Pingli Sun
  • YZYinbin Zhang
    Yinbin Zhang

Abstract
Background: The current National Comprehensive Cancer Network (NCCN) guidelines for non-small cell lung cancer (NSCLC) recommend that surgeons sample is not clear. We aimed to define a minimal number of examined lymph nodes for removal or sampling for optimized nodal staging recommendation, with a focus on T1–3N0M0 patients. Methods: A total of 55,101 consecutive patients were selected, including 52,099 patients with US Surveillance, Epidemiology, and End Results (SEER) data and 3,002 patients in a Chinese multicenter database from 11 thoracic referral centers, who underwent complete resection plus lymph node dissection or sampling for stage T1–3N0M0 NSCLC. Propensity score-matching analysis was performed with R software, and a cut-off value was calculated using X-tile software. Survival was evaluated using the Kaplan-Meier method and Cox proportional hazard models. Results: Five-year survival rates with respect to total examined lymph nodes numbers (examined lymph nodes vs. examined lymph nodes ≥10) were 69% and 64% (group A), 66% and 63% (group B), 62% and 58% (group C), 81% and 75% (group D). There were significant differences between examined lymph nodes 10 in each group (PConclusions: A minimum of 10 examined lymph nodes would significantly improve T1–3N0M0 NSCLC prognosis and patients’ survival rates if implemented as a minimum standard for lymphadenectomy. Therefore, we recommended a minimum of 10 examined lymph nodes for T1–3N0M0 patients.